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KAJIAN DINAMIK MOLEKUL  
KESAN MUTASI NEURAMINIDASE  
KEPADA RINTANGAN OSELTAMIVIR  
 
ABSTRAK 
 
Peningkatan laporan mengenai virus influenza yang resistan terhadap 
oseltamivir (OTV) (contohnya mutasi H274Y pada neuraminidase, NA) telah menarik 
banyak perhatian para penyelidik. Banyak kajian telah dilakukan untuk memahami 
mekanisme rintangan OTV pada NA H274Y. Namun, sebahagian besar kajian pada 
H274Y hanya tertumpu kepada sistem ubat-terikat, sementara kesan langsung mutasi 
terhadap NA sendiri, sebelum mengikat ubat, masih belum jelas. Oleh itu, analisis 
dinamik molekul NA pada bentuk apo, diikuti dengan analisis komponen utama dan 
pengiraan tenaga interaksi, telah dijalankan untuk mengkaji perubahan struktur pada 
tapak ikatan NA, sebagai kesan daripada mutasi H274Y. Gangguan tapak ikatan NA 
kerana mutasi H274Y bermula daripada kesan tolakan Y274 pada loop-250 telah 
menyebabkan perubahan jaringan ikatan hidrogen di sekitar residu 274. Putaran rantai 
sisi W295 telah menyebabkan loop-340 bergerak ke atas dan mengakibatkan laluan 
pengikatan OTV telah terjejas kerana gangguan dari tapak ikatan NA, berdasarkan 
laporan sliding-box docking. Kajian ini juga memperlihatkan pentingnya kelompok 
berfungsi pada kedudukan C6 dari asid sialik. Selain itu, dua hal yang mungkin boleh 
digunakan untuk menjelaskan perbezaan kesan H274Y pada subjenis N1 dan N2 ialah: 
residu 245 dan residu yang membentuk interaksi π dengan W296. Pendekatan yang 
sama telah dilakukan untuk menjelaskan kesan mutasi N294S subjenis N1 dan R292K 
subjenis N9. Gangguan pengikatan kalsium terjadi pada mutan N294S, dan perubahan 
xix 
struktur teras NA telah berlaku pada mutan R292K. Buat pertama kalinya, mekanisme 
rintangan OTV telah dikaji secara terperinci dalam situasi sebelum NA sebelum terikat 
ubat. Hasil kajian ini diharapkan dapat meningkatkan kefahaman mengenai kes 
rintangan OTV dan bermanfaat untuk reka bentuk ubat anti influenza yang baru. 
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MOLECULAR DYNAMICS STUDIES  
OF THE EFFECT OF NEURAMINIDASE MUTATION  
ON OSELTAMIVIR RESISTANCE 
 
ABSTRACT 
 
The increased number of reports on oseltamivir (OTV) resistant strains of 
influenza virus (e.g. H274Y mutation on its neuraminidase, NA) has created some 
causes for concern. Many studies have been conducted to uncover the mechanism of 
OTV resistances in H274Y NA. However, most of the reported studies on H274Y were 
only focused on drug-bound-system, while direct effects of the mutation towards NA 
itself, prior to drug binding, remains unclear. Therefore, molecular dynamics of NA in 
apo-form, followed by principal component analysis and interaction energy 
calculation, were performed to investigate the structural changes of NA binding site, 
as a result of H274Y mutation. The disruption of NA binding site due to H274Y, 
initiated by the repulsive effect of Y274 on 250-loop - which in turn altered the 
hydrogen bond network around residue 274, was observed. The rotated W295 side 
chain has caused the upwards movement of 340-loop. Consequently, sliding-box 
docking results suggested that the binding pathway of OTV was compromised due to 
this binding site disruption. This study also highlighted the importance of functional 
group at position C6 of sialic acid mimicry. Moreover, two possible keys to explain 
the differences of H274Y effects in N1- and N2- subtypes, were proposed: residue 245, 
and the residue which formed π-interaction with W296. Similar approaches were 
applied to explain the effects of N294S and R292K mutations in N1- and N9- subtypes, 
respectively. The disruption of calcium binding in N294S mutant was observed. While 
xxi 
the changes of NA’s core structure occurred in R292K mutant. For the first time, the 
mechanism of OTV resistance was extensively studied from the state of NA prior to 
drug binding. It is hoped that these results could improve the understanding of OTV 
resistances and shed some light on the design of novel anti-influenza drug. 
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CHAPTER I 
INTRODUCTION 
 
1.1. Statement of the Problem 
Influenza, also referred to as “flu”, is a disease which transmission could 
reach pandemic levels. The worst influenza pandemic was estimated to have killed 
more than 50 million people in year 1918 (Taubenberger and Morens, 2006). 
Influenza is caused by influenza virus, which has evolved and mutated over time, 
posing serious challenges in developing effective therapies. In the last century, at 
least three influenza pandemics have been reported: Spanish Flu (H1N1) in year 
1918, Asian Flu (H2N2) in year 1957 and Hongkong Flu (H3N2) in year 1968. In 
2009, a pandemic swine flu (H1N1) which has killed about 18,500 people, was 
reported. To complicate matters, avian influenza virus, that originally carried among 
birds (e.g. H5N1), has also been a major threat due to its high fatality rate when 
transmitted to human. In 2011, 34 deaths out of 62 cases of H5N1 were reported 
from Bangladesh, Cambodia, China, Egypt, and Indonesia (Health & Human 
Services, 2013). In 2013, a novel avian influenza virus, H7N9, which was not 
previously known to infect human, has resulted in 37 deaths out of 132 patients in 
China (CDC, 2013; WHO, 2013a; WHO, 2013b). 
The glycoproteins on the surface of influenza virus, i.e. hemagglutinin (HA) 
and neuraminidase (NA), have become the targets for the development of anti-
influenza (as reviewed in Itzstein and Thomson, 2009). Up to 2013, there have been 
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18 HA and 11 NA subtypes of influenza (Tong et al., 2013). Although HA is the 
main target for vaccine development, to develop ligands that can tighly bind to HA is 
very challenging. It is due to the shallow and less-energetic receptor binding site of 
HA (Yusuf et al., 2013). Whilst structural conservation of NA binding site, NA’s 
important role in viral infection, and the availability of NA crystal structures in 
Protein Data Bank are the major reasons NA is the most targeted protein for 
inhibitors in anti-influenza drug design (as reviewed in Itzstein and Thomson, 2009). 
Tamiflu (a prodrug for oseltamivir carboxylate, OTV) and Relenza (zanamivir, 
ZMR) are two examples of NA inhibitors approved by FDA to be released to the 
market.  
Although Tamiflu is the world’s largest stockpile of anti-influenza drug, and 
most dominantly used for influenza treatment, the increased report of OTV resistant 
strains (e.g. H274Y, R292K, N294S, including the recent H7N9 China strain) has 
created some causes for concern (Moscona, 2005; Hayden, 2006; Abed et al., 2006, 
Hurt et al., 2009; Soundararajan et al., 2009; Liu et al., 2013; Gillman, 2015). Hurt et 
al. (2009) reported that 64% of H1N1 samples from ten countries including 
Australia, Malaysia, and South Africa were of H274Y mutants. Moreover, 70% 
occupancy of H274Y in H1N1, circulating in Norway, has indicated that the mutant 
is transmissible among humans, even in the absence of drug pressure (Stephenson et 
al., 2009). Recently, an in vitro study showed that once the virus evolved, H274Y 
mutation persisted after the withdrawal of the drug in the experiment (Renzette et al., 
2014). All these phenomena suggest the careful use of OTV to limit the development 
of mutant virus. It is noted that the efficacy of ZMR to H1N1 was not affected by 
H274Y mutation. However, ZMR showed poor oral bioavailability due to its polarity 
problem. 
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Therefore, deep understanding on the mechanism of OTV resistances, 
especially at the molecular/atomic level, has become very important. To date, there 
are many studies on mutagenesis (Wang et al., 2002), crystallography (Collins et al., 
2008), and molecular dynamics simulation (Malaisree et al., 2009; Park and Jo, 
2009; Wang and Zheng, 2009; Le et al., 2010; Rungrotmongkol et al., 2010; 
Karthick et al., 2012) have been conducted in the  attempts to uncover the 
mechanism of OTV resistances in NA. However, most of reported studies on OTV 
resistances were focused on the changes of drug-receptor interaction of OTV 
(Malaisree et al., 2009; Park and Jo, 2009; Wang and Zheng, 2009; Rungrotmongkol 
et al., 2010; Li et al., 2012; Ripoll et al., 2012; Woods et al., 2012; Woods et al., 
2013), while the direct consequence of these mutation points towards the dynamics 
behavior of NA binding site, albeit prior to drug binding, still remains unclear. 
Molecular dynamics (MD) simulation has been a valuable method to investigate the 
structural behavior of protein, and also to rationally predict the “future state” of a 
particular conformation. Hence observing the mutation effect to NA’ structure has 
become feasible through MD simulation. A mutagenesis study by Wang and 
colleagues (Wang et al., 2002) implied that the native-histidine itself, at position 274, 
might have a distinct role in the wild type NA. Understanding of the role of H274 
should be useful to interpret the structural changes of NA binding site that occurred 
due to mutation, when histidine being replaced with tyrosine (H274Y). It is worth 
noting that histidine has three possibilities of protonation states in physiological pH. 
Moreover, the affinity of OTV towards H274Y-carrying N2-subtype was unaffected, 
indicating the importance of residues surrounding the mutation point. In addition, 
N294S and R292K, respectively N1 and N9 subtypes, are the other mutations which 
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related to OTV resistances. The effect of these two mutations to the structural 
behavior of NA, prior to drug binding, is also still elusive. 
1.2. Aims and Objectives 
Based on the problem statement above, the aim of this work is to study the 
mechanism of OTV resistances in NA using molecular dynamics simulations of 
various NA systems in apo (ligand-free) form. Specifically, the objectives of this 
work were to investigate: 
1. the specific role of native-histidine at position 274 in wild type, 
2. the direct effects of H274Y to the integrity of NA binding site, 
3. the effects of H274Y in relation with OTV binding, 
4. the effects of H274Y in N2-subtype, and to compare with that in N1-subtype, 
5. the effects of N294S and R292K mutations on N1 and N9 subtypes, respectively. 
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CHAPTER II 
LITERATURE REVIEW 
 
2.1. Influenza Virus 
Influenza virus is an RNA virus of Orthomyxoviridae family, which 
serologically divided into three subtypes: A, B, and C. Influenza A virus possesses 
higher pathogenicity to human compared to Influenza B and C. Influenza A has 8 RNA 
segments, i.e. NA, HA, NP, NS, M2/M1, PA, PB1 and PB2. Amongst these, four gene 
products have been targeted for drug development, i.e. HA, NA, M2 and RNP  (Figure 
2.1) (Du et al., 2012; CDC, 2009). RNP (ribonucloprotein) is formed by NP, RNA, and 
three polymerase subunits (PA, PB1 and PB2) (Du et al., 2012).  
Influenza virus A is named based on the subtypes of its two main surface 
glycoproteins: hemagglutinin (HA) and neuraminidase (NA) (as reviewed in Itzstein 
and Thomson, 2009). There are 18 and 11 subtypes of HA and NA, respectively (Tong 
et al., 2013). 
HA, a surface glycoprotein of influenza virus (Skehel and Wiley, 2000) plays 
a role in receptor-binding (sialic acid) and membrane fusion glycoprotein of the 
influenza virus (Wiley and Skehel, 1987). Due to its high immunogenicity, HA is a 
main target for vaccine development although development of small-molecule 
inhibitors of HA has also been reported (Matsubara et al., 2010; Gambaryan et al., 
2008). The major challenge in targeting HA for vaccine is the accumulated mutations 
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in its antigenic site. In addition, its shallow and less-energetic binding site also 
contributed to the challenge in developing ligand which can tightly bind on HA (Yusuf 
et al., 2013).  
NA is another glycoprotein on the surface of influenza virus, which function is 
to remove terminal sialic acid from mucins thus helps HA to disaggregate, which in 
turn allows the virus to finally reached the host cell (Wagner et al., 2002). NA is also 
required at the last stage of infection by removing NANA (neuraminic/sialic acid) from 
the viral envelope thus releasing the virus progeny to further infect another host cell 
(Palese et al., 1974).  
 
 
Figure 2.1. Four drug target of influenza virus: HA, NA, M2 ion channel and 
ribonucleoprotein (RNP) (taken from http://www.cdc.gov/flu/images/ 
h1n1/3D_Influenza_transparent_key_pieslice_lrg.gif).  
 
(HA) 
(NA) 
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A comprehensive life cycle of influenza A virus is presented in Figure 2.2 (Das 
et al., 2010). In order to enter the virus cell, initially, HA binds to the sialic acid receptor 
on the surface of host cell.  Low pH in endosome, which is supposed to be the defense 
mechanism of cell against foreign material, triggers a conformational change in HA 
which allows the virus fusion with endosomal membrane (endocytosis). In addition, 
the acidic condition also enables protons to flow into the virus through M2 ion channel. 
Thus, viral ribonucleoproteins (vRNP) dissociate from M1 matrix protein. The 
released vRNP, which possesses nuclear localization sequences, enters the nucleus 
accordingly. Once inside the nucleus, viral polymerase starts the synthesis of viral 
mRNA which in turn being transported to the cytoplasm for further translation process 
to become viral proteins. These viral surface proteins, i.e. HA, NA and M2 ion channel, 
are processed in the host’s endoplasmic reticulum, then glycosylated in Golgi 
apparatus before they are transported to the cell membrane. As for vRNPs, its complex 
with M1-NS2 proteins interacts with human chromosome region maintenance 1 
(CRM1) protein which enable them to be exported from the nucleus to the cytoplasm 
and finally reaching the cell membrane to be incorporated into new virus that is 
budding out. HA and NA of new viruses contain terminal sialic acid that hold the 
viruses on the cell surface. At the last stage, NA of the new viruses cleaves these sialic 
acid residues, helping the virus to be released from the host cell and spread to continue 
its infectious action to the other cells (Das et al., 2010).  
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Figure 2.2. Life cycle of influenza A virus (Das et al., 2010). 
 
It has been evidenced that influenza virus evolved through antigenic shift and 
antigenic drift. The latest pandemic H1N1 2009 strain is known to be derived from 
Eurasian swine H1N1 and North American swine H1N1, which are descendants of 
avian influenza gene pool and 1918 human H1N1, respectively. As mentioned above, 
avian influenza and human influenza viruses have distinct characters when transmitted 
into human. The first one is mostly high pathogenic but slowly spread among human, 
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while the latter has lower pathogenicity but easily spread among human. Therefore, 
one of the worst scenario in the evolution of influenza virus is the combination of two 
dangerous features: highly pathogenic and highly transmissible to human (Morens et 
al., 2009). For this reason, it is not an exaggeration to say that human influenza 
pandemics are unavoidable, but the extent of victims’ number affected is 
unpredictable.  
In the evolution of influenza virus, genetic changes have occurred since the 
influenza pandemic in 1918, either through antigenic shift or antigenic drift. Antigenic 
shift occurred when a strain of virus is able to jump from one species to another, e.g. 
avian to human. There are three different schemes of antigenic shift: (1) genetic mixing 
of human influenza and bird influenza in an intermediate host cell (swine) as mixing 
vessel, (2) the ability of avian influenza strain to directly jump into human without 
genetic change, and (3) the ability of avian influenza strain to enter an intermediate 
host (swine) and then to human without genetic changes (see Figure 2.3). 
As opposed to antigenic shift, antigenic drift is a natural mutation in a strain of 
influenza virus which enable the virus to escape from the present antibody. For 
example, genes of HA in influenza virus have undergone some mutations which 
consequently changed the structural shape of HA. Thus, antibody which previously 
binds to HA loss its complementarity with HA and allows the newly mutated influenza 
virus to infect host cell (see Figure 2.4). 
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Figure 2.3. Antigenic shift in influenza virus. (US National Institute of Allergy and 
Infectious Diseases (NIAID)). 
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Figure 2.4. Antigenic drift in influenza virus (US National Institute of Allergy and 
Infectious Diseases (NIAID)). 
 
Antigenic shift and drift in influenza virus have been proven as sources of 
repeating pandemics and endemics of influenza. The latest pandemic influenza in 
2009, known to be caused by H1N1, was found as the results of gene re-assortments 
of swine influenza virus which is also another genetic product of the remarkable 1918 
virus (Morens et al., 2009).  
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Figure 2.5 shows that 2009 H1N1 virus is the fourth-generation descendant of 
the 1918 virus. This virus is also a descendant of Eurasian swine H1N1 and triple-
reassortant swine H1N2. The latter is derived from human H3N2 and North American 
swine H1N1, which is also a descendant of 1918 human H1N1. Furthermore, it is 
known that 1918 H1N1 and 1979 H1N1 were all derived from avian influenza A gene 
pool. In short, part of genes in pandemic human 2009 H1N1 strain were also donated 
from avian influenza A genes pool (Morens et al., 2009). 
 
Figure 2.5. Genetic relationship of influenza virus among human, swine, and avian 
influenza A gene pool (taken from Morens et al., 2009).  
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“Luckily”, the influenza virus appeared to evolve towards optimal 
transmissibility rather than pathogenicity. This is reflected from the decreased severity 
caused by influenza pandemics over time, although the advances in medicine and 
public health have also contributed. It is appeared that those highly pathogenic strains 
of influenza virus, e.g. H5N1 and H7N9, are not optimally transmissible. Nevertheless, 
there is still a possibility of entirely new virus which possesses the two most dangerous 
features, i.e. highly transmissible and pathogenic in human. (Morens et al., 2009). One 
of recent products of the evolution of influenza virus is avian influenza H7N9, which 
was found in 132 patients and resulted in 37 deaths in China (as of May 30, 2013). 
This new virus is different from other H7N9 viruses previously found in birds and for 
the first time in history has been shown to infect human  (CDC, 2013).  
Major efforts in preventing and controlling the influenza virus are through the 
development of vaccine and antiviral agents (Stiver, 2003). However, the current in-
market vaccine is still susceptible to the antigenic evolution occurred in influenza virus 
(Gerhard W, 2006), thus it needs to be annually reformulated to cope with its limited 
protection in cases of antigenic mismatch (Pica and Palese, 2013). For this reason, 
antiviral agent can act as a first line of defence against the spread of influenza while 
providing some time for the completion of effective vaccine development in human 
pandemic setting. Currently, the largest stockpile of anti-influenza is oseltamivir 
(OTV), branded as Tamiflu, a NA inhibitor. NA is one of the most targeted proteins in 
drug discovery for influenza, mainly due to its conserved nature and important role in 
virus infection. Unfortunately, influenza virus can also build resistance towards NA 
inhibitors, thus the continuous efforts in antiviral development become very important 
(Itzstein and Thomson, 2009). Some of important mutations related to OTV-
resistances in NA are H274Y, R292K and N294S. Among these three mutations, 
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H274Y has been a major concern in N1 subtype of NA due to its high resistance on 
OTV, without affecting the viability of influenza virus. Interestingly, H274Y has 
caused NA to become resistant to OTV, but not to zanamivir (ZMR), another licensed 
drug for influenza, branded as Relenza. Despite its high affinity on H274Y mutant, 
ZMR is known for its polarity problem and poor bioavailability. Although N2 subtype 
with H274Y does not naturally exist, studies have shown that H274Y-recombinant of 
N2 subtype is still sensitive to OTV (Abed et al., 2006; Wang et al., 2002). 
It is reported that the pathogenicity of H5N1 strains was not affected by N294S 
mutation (Hay et al., 2008). Whilst, R292K mutation has resulted in poor viability and 
transmissibility of the virus despite its high level resistance on OTV (Carr et al., 2002; 
Herlocher et al., 2002). Recent H7N9 outbreak has also been reported to complicate 
OTV resistances caused by R292K mutation (Hu et al., 2013). 
2.1.1. Neuraminidase (NA) 
NA is a homotetrameric protein, in which, each monomer consists of six 
topologically identical four stranded antiparallel β-sheets and arranged like a propeller 
blades (Varghese et al., 1983). NA is an enzyme which cleaves the α-2,3 and α-2,6 
glycosidic bond between terminal sialic acid (neuraminic acid, NANA) and galactose. 
The active site of NA (Figure 2.6) is composed of ten polar residues (e.g. arginine, 
aspartic acid, and glutamic acid) and four hydrophobic residues (e.g. alanine, 
isoleucine, and tryptophan) (Stoll et al., 2003). The active site of NA is conserved, 
hence NA is a favorable targeted protein for inhibitors in anti-influenza drug design, 
in addition to the availability of NA crystal structures in Protein Data Bank (Itzstein 
and Thomson, 2009).  
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The substrate-binding site (the top region of NA), is made up of loops, namely 
150-, 200-, 220-, 250-, 270-, 300-, 320-, 330-, 340-, 370-, 400-, and 430- loops (see 
Figure 2.6a). The important role of 150-loop in inhibitor binding has been reported 
(Wu et al., 2013). While loops containing residues H274 and N294 (270- and 300- 
loops, respectively) were suggested as negatively-charged binding funnel of NA (Le 
et al., 2010). H274, R292 and N294 are points of mutation usually observed in NA. 
H274 is located at 270-loop while R292 and N294 are located at 300-loop. Amongst 
these three mutations, only R292 directly interacts with the ligand. Whilst H274 and 
N294 were regarded as two of the framework residues to support the structure of the 
catalytic site (Gubareva et al., 1997; Klenk et al., 2008). Although H274 and N294 do 
not directly interact with the ligand, it is expected that the mutations of H274Y and 
N294S would affect the conformation of surrounding loops, altering the integrity of 
NA’s active site and the interaction of OTV-NA. There are two major groups of NA, 
i.e. Group-1 (N1, N4, N5 and N8 subtypes) and Group-2 (N2, N3, N6, N7 and N9) of 
NA, respectively (Collins et al., 2008). Besides N1-subtype (e.g. H1N1 and H5N1 
viruses), N2-subtype also contributed to the major pandemics, i.e. H2N2 (Asian Flu) 
and H3N2 (Hongkong Flu) (Cox and Subbarao, 2000). In addition to H1N1, the H3N2 
virus is also a major cause of severe epidemics. Therefore the understanding of N2-
subtype in drug resistant case is critical for the preparedness against highly 
transmissible virus (Wu et al., 2013). The overlaid structures of N1 (PDB 2HU4 
(Russell et al., 2006)) and N2 (PDB 1NN2 (Varghese and Colman, 1991)), showed that 
the active site residues in N1- and N2- are mostly conserved, except residues 246 and 
347 (serine and tyrosine in N1 while alanine and glutamine in N2) (Figure 2.6b). For 
this reason, the difference of resistance level of H274Y mutant of N1- and N2- 
subtypes towards OTV (Wang et al., 2002), is also interesting to be studied.  
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(a) 
 
(b) 
Figure 2.6. (a) Homotetramer NA which binding site located on top region. NA 
binding site composed mostly by polar residues (adapted from Stoll et al., 
2003). (b) Residues within 5 Å from OTV in N1- and N2- subtypes 
(colored in green and orange, respectively). The figure was generated 
using Accelrys Visualizer and VMD.  
OTV 
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2.2. The Development of Neuraminidase Inhibitors 
The first NA inhibitor, 2-deoxy-2,3-didehydro-N-acetylneuraminic acid 
(DANA) which is a transition state analogue of NANA (NA substrate), was first 
reported by Meindl et al. (1974). Since then, DANA has served as a lead compound 
for the current FDA-approved neuraminidase inhibitors: Relenza (zanamivir) (von 
Itzstein et al., 1993) and Tamiflu (oseltamivir phosphate) (Kim et al., 1997) (reviewed 
in De Clercq, 2006).  
Based on the crystal structure of NA (N2-subtype), von Itzstein and colleagues 
found that the binding pocket for C4 position of DANA may accommodate the larger 
basic group. Further investigation has led them to introduce guanidino moiety to fill 
up this site, which proven later to significantly interacted with E119 and E227, 
displaced a water molecule at C4 binding site, thus possessed a slow binding 
properties. This modified compound, zanamivir (ZMR), showed sub-nanomolar 
inhibition against influenza A (N2-subtype). Unfortunately, ZMR has poor oral 
absorption due to its polar nature. Therefore, ZMR is only delivered through inhalation 
to reach the primary target of infection (reviewed in Itzstein and Thomson, 2009).  
The structural information derived from NA in complex with ZMR, DANA, 
and other related compounds have again been found useful in designing other potent 
inhibitors. It was found that the oxygen atom at dihydropyran ring on these compounds 
(e.g. ZMR, DANA) does not form important interaction with the active site (Taylor 
and von Itzstein, 1994), which indicated the possibility to replace this oxygen atom 
with carbon atom. Consequently, Kim and colleagues developed a new NA inhibitor 
based on carbocyclic, cyclohexene-based which was derived from shikimic acid (Kim 
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et al., 1997). They observed that the hydrophobic backbone of glycerol moiety in 
DANA and ZMR interacted with NA active site, thus suggested the possibility to 
replace the whole glycerol side chain with hydrophobic alkyl group in order to improve 
the oral bioavailability of the compound. Finally, an optimized structure resulted from 
further structure-activity relationship (SAR) studies, i.e. oseltamivir carboxylate 
(OTV) is produced and now marketed as Tamiflu (prodrug of OTV). As compared to 
DANA, OTV has pentyloxy group at position C6 (as replacement of glycerol moiety 
in DANA and ZMR), and an amino group at position C4 (Figure 2.7). Moreover, OTV 
also possessed a slow binding characteristic due to the requirement of hydrophobic 
sub-pocket formation by E276 and R224 during its binding (Kati et al., 1998; Itzstein 
and Thomson, 2009).  
After the discovery of OTV, the overlaid crystal structures of a furanose isomer 
with DANA in complex with N9 subtype has revealed that the four functional groups 
(side chains) in both complexes had similar orientation and interactions in the binding 
site. Therefore, it was concluded that the central ring is not an absolute factor in the 
development of potential NA inhibitors. Instead, it is the relative position of the 
functional groups in the active site which is important (Babu et al., 2000). For this 
reason, cyclopentane-based compounds (different central ring from the previous 
compounds) were developed and as a result peramivir (PMV) was discovered. PMV 
possesses a branched 2'-ethylbutyl side chain (analogue with OTV's pentyloxy) which 
is expected to have similar features with OTV in optimal interaction with the 
hydrophobic sub-pocket in NA active site. As for C4 position, PMV has a guanidino 
moiety similar to ZMR. In 2006, FDA approved the usage of PMV in injectable 
formulation (reviewed in Itzstein and Thomson, 2009).  
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In 2009, Yamashita and colleagues (Yamashita et al., 2009) reported the new 
potent NA inhibitors, i.e. laninamivir (LNV) and its prodrug: laninamivir octanoate. 
LNV possesses a guanidino group at position C4 and polyhydroxy group at position 
C6, similar to ZMR. However, at position C6, one of hydroxyl at 1'-glycerol was 
replaced with methoxy group. Moreover, LNV was found to be active against N1-N9 
subtypes, including OTV resistant strain, i.e. H274Y mutant. In addition, it is reported 
that its prodrug was shown to have long-acting properties as NA inhibitor. LNV 
showed a good efficacy in mouse model despite being administered 7 days before 
influenza infection (Yamashita, 2010), whereas Relenza and Tamiflu required twice-
daily administrations for the treatment. The long-acting properties of LNV prodrug 
was predicted due to its long retention in the lung. However, further clinical study 
(Watanabe et al., 2010) has shown that LNV prodrug was not significantly better that 
OTV in treating H274Y H1N1 in adult patients. It is suggested that in adult patients, 
LNV octanoate was slowly processed into its active form (Vavricka et al., 2011). 
Nevertheless, in 2010, LNV has been approved for anti-influenza drug in Japan and 
marketed under name of Inavir. The chemical structure of compounds reviewed above, 
are presented in Figure 2.7. 
Further development of NA inhibitors, based on OTV structure, were 
performed by Xie et al. (2014) and Mooney et al. (2014). The new structures were 
designed by extending the amino group of OTV (at C4 position) to target the 150-
cavity of NA. Two derivatives showed better potency against H5N1 NA than OTV 
(Xie et al., 2014). In another study, introducing the guanidine group to substitute the 
amino group of OTV also improve the ligand binding with NA of H1N1 and H5N1 
(Mooney et al., 2014).  
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Figure 2.7. Three dimension chemical structures of NANA (substrate), DANA, ZMR, 
OTV, PMV, LNV and LNV octanoate. The figure was generated using 
Accelrys Visualizer. 
 
2.3. Resistance to Neuraminidase Inhibitors 
Since Tamiflu is the world’s largest stockpile of anti-influenza drug, the 
increased report of OTV resistant strains has raised some awareness (Hayden, 2006; 
Moscona, 2005; Soundararajan et al., 2009; Hurt et al., 2009; Liu et al., 2013; Abed et 
al., 2006; Stephenson et al., 2009). Most recently, in 2015, Gillman and colleagues 
suggested that exposure of OTV to the aquatic environment might contribute to the 
evolution of avian influenza virus strain that are potentially pathogenic to human 
(Gillman et al., 2015). For these reasons, the careful use of OTV is critical to limit the 
development of mutant virus. Therefore, deep understanding on the mechanism of 
OTV resistances, especially at the molecular/atomic level, has become very important.  
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Figure 2.8 presents the overview of many studies which conducted in an 
attempt to uncover the mechanism of OTV resistances due to H274Y mutation (Wang 
et al., 2002; Collins et al., 2008; Park and Jo, 2009; Malaisree et al., 2009; Wang and 
Zheng, 2009; Le et al., 2010; Rungrotmongkol et al., 2010; Karthick et al., 2012). In a 
mutagenesis study (Wang et al., 2002), it was observed that residues with bulkier side 
chain (i.e. tyrosine, phenylalanine) reduced the NA sensitivity towards OTV, by 
posing steric hindrance for reorientation of the nearby E276. The rearrangement of 
E276 was required to form a proper hydrophobic pocket for OTV (Itzstein and 
Thomson, 2009; Kati et al., 1998). This effect, however, was not observed when 
involved smaller residues or ligands with glycerol moieties attached to them, such as 
zanamivir (ZMR) and 4-amino-DANA (See Table 2.1). Interestingly, OTV affinities 
in H274Y mutant of recombinant H3N2 was not affected (Wang et al., 2002), 
suggesting that the differences in residues surrounding position 274 in N2 and N1 
subtypes, play an important role in contributing the resistance to OTV. 
 
 
Figure 2.8. Binding mode interaction of OTV (green colored sticks) in NA's active site 
and the overview of hypotheses on H274Y effects towards the mechanism 
of OTV resistance. The figure was generated using Accelrys Visualizer. 
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Table 2.1. The effect of different size of amino acid’s side chain at the position of 
274 towards Km values of 2′-(4-Methylumbelliferyl)-α-D-N-
acetylneuraminic acid (MUNANA) and Ki values of OTV, ZMR, and 4-
amino-DANA (adapted from Wang et al., 2002). 
Type of 
recombinant NA 
(A/WS/33 H1N1) 
Km (µM) 
of 
MUNANA 
Ki (nM) 
OTV ZMR 4-amino-DANA 
Wild type (H274) 
H274G 
H274S 
H274N 
H274Q 
H274F 
H274Y 
31 
100 
110 
133 
125 
57 
55 
0.3 
0.2 
0.1 
0.1 
0.5 
86.0 
105.0 
0.1 
5.7 
14.9 
6.0 
3.8 
0.4 
0.3 
50 
1140 
890 
1250 
940 
130 
150 
 
The results obtained from the mutagenesis study (Wang et al., 2002) was 
supported by the NA crystal structures of H274Y mutant (from H5N1 virus) in 
complex with OTV and ZMR (Collins et al., 2008). As observed in the crystal structure 
of H274Y-OTV complex (PDB ID: 3CL0), Y274’s bulky side chain pushes E276’s 
carboxylate side chain ~2 Å deeper into the binding site (compared to that in the wild 
type). This resulted in the disruption of hydrophobic pocket which could no longer 
accommodate OTV's pentyloxy group. However, the disruption did not affect the two 
hydroxyl groups of ZMR to maintain the interaction with the carboxylate group of 
E276 (Figure 2.9). 
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a b 
Figure 2.9. (a) The molecular basis of N1 resistance towards OTV derived from 
H274Y crystal structure (PDB ID 3CL0, green colored carbon atoms) 
which overlaid with wild type (yellow colored carbon atoms. (b) The 
overlaid of H274Y-ZMR complex (PDB ID 3CKZ, green colored carbon 
atoms) with wild type (Collins et al., 2008). 
 
This observation was in agreement with the molecular dynamics (MD) studies 
on H274Y-OTV complex system, where the conformational change of E276 (Li et al., 
2012; Wang and Zheng, 2009) and the loss of bidentate salt bridge between E276 and 
R224 (Wang and Zheng, 2009) were also observed. The MD results showed that Y274 
forced the rotation of E276’s carboxylate group’s side chain by 115° thus altered the 
hydrophobic sub-pocket. Due to the altered  binding site, the pentyloxy group of OTV 
was rotated by 125°, thus reducing the binding energy by ~5 kcal/mol (Malaisree et 
al., 2009) (Figure 2.10).  
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Figure 2.10. Rotational changes of binding residues (Y274, E276 and R224) and 
pentyloxy group of OTV (Tor-X, Tor-Y and Tor Z) which represented in 
(a) molecular diagram and (b) plot of dihedral angle distribution (taken 
from Malaisree et al., 2009). 
 
In another MD simulation study of OTV-H274Y complex system, it has been 
proposed that the origin of OTV resistance was due to the infiltration of water 
molecules into the binding site (Park and Jo, 2009) (Figure 2.11). MD studies of 
various mutants (e.g. H274Y, N294S and R292K) in complex with OTV 
(Rungrotmongkol et al., 2010; Ripoll et al., 2012) indicated that each mutation has 
resulted in different conformational changes at the active site. Therefore, the 
mechanism of drug resistances in various mutants should not be generalized (Figure 
2.12). Furthermore, the differences between the buried surface areas of OTV’s 
pentyloxy in the WT and in H274Y (Table 2.2), were not in agreement with those 
suggested from the crystallography data (Collins et al., 2008). 
 
